Back |
home / stock / abeo / abeo message board
Subject | By | Source | When |
---|---|---|---|
Emylers: ACCP Financials 07/16/2014 20:22:27 Access Pharmaceuticals, Inc. Period Ending Dec 31, 2013 | Emylers | investorshangout | 07/17/2014 1:22:23 AM |
Stock Tracker: Latest Access Pharmaceuticl (ACCP) Headlines Access Pharmaceuticals Announces Publica | Stock_Tracker | investorshangout | 03/08/2014 9:37:55 PM |
chartguy89: ACCP 0.375 Stock Charts $ACCP 1 Month Chart | chartguy89 | investorshangout | 03/05/2014 11:02:20 PM |
Stock Tracker: ACCP Recent News Access Pharmaceuticals Announces Publication Of MuGard Clinical Data | Stock_Tracker | investorshangout | 03/02/2014 4:29:24 AM |
chartguy89: ACCP Stock Charts Saturday, February 22, 2014 at 12:35:25 AM $ACCP Last: -0.012 | chartguy89 | investorshangout | 02/22/2014 5:35:37 AM |
News, Short Squeeze, Breakout and More Instantly...
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
CLEVELAND and LONDON, July 11, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a cell and gene therapy company with proprietary adeno-associated virus (AAV)-based capsids, and Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, today announced ...
CLEVELAND, July 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., and Chief Commercial Officer, Madhav Vasanthavada, Ph.D., M.B.A., will participate in a virtual fireside chat at the Sti...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ABEO on July 3, 2024 06:07AM ET. ABEO was trading at $4.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...